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Background: Tumor-infiltrating antigen-presenting cells (APCs), involving tumor-associated
macrophages and tumor-infiltrating dendritic cells, play an important role in tumor
immunity and immune escape. The aim of this study was to determine whether tumor
infiltrating CD11bþ APCs may affect tumor progression and clinical outcome.
Methods: The immunohistochemical analysis was used to evaluate the expression of
CD11b, FOXP3, and CD8 in 214 gastric cancer tissues. Concentrations of immunosuppres-
sive cytokines in medium conditioned by gastric cancer cells were measured by enzyme-
linked immunosorbent assay. Effects of addition of tumor-conditioned media on CD11cþ
cells were examined by flow cytometry.
Results: Almost all tumor-infiltrating CD11bþ cell expressed CD11c and was considered to
be APCs. High CD11bþ cell infiltration was significantly correlated with huge tumor, posi-
tive venous invasion, lymph node metastasis, and tumor, node, metastasis stage. Patients
with high CD11bþ cell infiltration had a poorer surgical outcome than those with low CD11b
infiltration. Multivariate analysis revealed that CD11bþ cell infiltration was one of the
independent prognostic factors. Tumor-conditioned medium obtained from several gastric
cancer cell lines contained immunosuppressive cytokines, transforming growth factor-
beta, interleukin-10, and vascular endothelial growth factor. The addition of tumor-
conditioned medium decreased the expression of major histocompatibility complex-II
and increased the expression of CD11b and programmed death ligand 2 on CD11cþ APCs.
Infiltration of CD11bþ cells significantly correlate with the degree of FOXP3þ cell infiltration
but not with CD8þ cell infiltration.
Conclusions: Tumor-infiltrating CD11bþ APCs affected local tumor cell-immune cell inter-
actions and correlated to the poor prognosis of the patients with gastric cancer.
ª 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.gical Oncology, Osaka City University Graduate School of Medicine, 1-4-3, Asahimachi,
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j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 6 ( 2 0 1 4 ) 1 9 2e2 0 0 1931. Introduction polyclonal anti-human anti-CD11b antibody (ab75476, 1:50Multiple immunohistochemical studies have elucidated the
relationship between immune cell infiltration and tumor
progression in several cancers. The presence of tumor-
infiltrating T lymphocytes has favorable prognostic value in
gastric cancer [1]. However, antitumor immunity has failed to
control tumor progression in patients with advanced gastric
cancer. The failure of the immune response has been due to
tumor resistance to immune attack or local inhibition of
cytotoxic T lymphocytes (CTLs). The precise mechanisms of
immunosuppression in gastric cancer have been unclear.
Antigen-presenting cells (APCs), including dendritic cells (DCs)
and macrophages, play a crucial role in the antitumor immu-
ne response. M1 macrophages secreting interleukin (IL)-12
promote protective Th1 responses; alternatively, activated M2
macrophages secreting IL-10 favor the establishment of toler-
ance and tumor progression [2]. As well as macrophages, DCs
have dual roles for tumor immunity. Immature DCs, which
retain their endocytic capacity, impair antigen presentation to
T cells [3,4]. Several studies have demonstrated that tumor-
infiltrating mature DCs are correlated with favorable prog-
nosis, but immature DCs do not have this correlation [5e8].
However, the underlyingmechanisms regarding the derivation
and local function of intratumoral DCs in their role of activating
CTLs remain unclear. CD11b is a type I transmembrane glyco-
protein also known as aM integrin, Mac-1, CR3, or C3biR. CD11b
functions in cell-cell and cell-substrate interactions and is
a receptor for iC3b, CD54 (ICAM-1), CD102 (ICAM-2), and CD50
(ICAM-3). In DCs, CD11b expresses part of the subset of dermal
or interstitial DC, monocyte DC, and Langerhans cells. The aim
of this study was to examine the relationship between infil-
tration of CD11bþ APCs and the progression of gastric cancer.2. Materials and methods
2.1. Patients
Human gastric cancer specimens were collected from 214
patients who underwent surgical resection for primary gastric
cancer at the Osaka City University Graduate School of
Medicine between 2005 and 2008. Patients who received
preoperative chemotherapy were excluded. Histologic type
was determined according to the Lauren classification [9].
Pathologic stage was determined according to the guidelines
of the TNM Classification of Malignant Tumours, 7th Edition
(International Union Against Cancer). Tissue specimens were
fixed in 10% formalin and embedded in paraffin, and 4-mm
thick serial sections of each patient’s tumor with the greatest
dimension were used for immunohistochemistry testing. The
study was approved by the medical ethical committee of the
Osaka City University Hospital and written informed consent
was obtained from each patient before treatment.
2.2. Immunohistochemistry
After antigen retrieval by autoclaving at 105C for 10 min, the
tissue sections were incubated overnight at 4C with rabbitdilution; Abcam, Cambridge, UK) or FOXP3 (ab2481, 1:50
dilution; Abcam) or CD8 (NCL-CD8-4B11, 1:40 dilution;
Leica, Newcastle, UK). The signal was amplified by
streptavidin-biotin complex formation and developed with
3,30-diaminobenzidine followed by counterstaining with
hematoxylin. For double staining for CD11b and CD11c,
rabbit polyclonal anti-human anti-CD11b antibody (ab75476,
1:50 dilution; Abcam) and mouse monoclonal anti-human
anti-CD11c antibody (ab52632, 1:50 dilution; Abcam),
donkey Cy3-conjugated anti-rabbit antibody (ab6816-1, 1:100
dilution; Abcam), and rabbit fluorescein isothiocyanate
(FITC)-conjugated anti-mouse antibody (ab6939, 1:1000 dilu-
tion; Abcam) were used. Double staining was investigated on
a Leica confocal microscope and with the Leica TCS-SP5,
Ver 1.6 software (Leica Microsystems GmbH, Wetzlar,
Germany). All cell counts were performed using an OLYMPUS
BX41 scope (Olympus, Tokyo, Japan) at 100 magnification
(10 objective and 10 eyepiece). Cases were scored blindly
with respect to clinicopathologic features. For each section,
10 areas of a representative field of tumor were assessed.
2.3. Cell lines
The human gastric cancer cell lines, OCUM-8, OCUM-12,
OCUM-2M, OCUM-2MD3 (established at our institute [10e13]),
MKN-45, MKN-74, KATO-III, and NUGC-4, were maintained in
Roswell Park Memorial Institute-1640 complete medium:
Roswell Park Memorial Institute-1640 medium (Wako, Osaka,
Japan) supplemented with 10% fetal bovine serum (Nichirei
Biosciences, Tokyo, Japan) and 2% penicillin and streptomycin
(Wako) at 37C with 5% CO2.
2.4. Generation of DCs from human peripheral blood
monocytes
Monocyte-derived DCs were generated from peripheral
mononuclear lymphocytes using the standard method, as
described previously [14]. Briefly, peripheral mononuclear
lymphocytes were plated in 100 20-mm tissue culture plates
at a density of 2.0 107 cells per dish in 5mL of AIM Vmedium
(Life Technologies, Carlsbad, CA) in the absence of serum.
Nonadherent cells were carefully removed. The remaining
cells were cultured for 6 d in AIM V medium (Life Technolo-
gies) with 2% heat-inactivated autologous human serum,
10 ng/mL recombinant human granulocyte macrophage
colony-stimulating factor (Miltenyi Biotec, Auburn, CA) and
IL-4 (Miltenyi Biotec).
2.5. Effects of gastric cancer cells on DCs in vitro
Cancer supernatant was obtained from 48-h culture medium
with confluent cancer cell lines and tested for cytokine
production including transforming growth factor-beta (TGF-
b), IL-10, and vascular endothelial growth factor (VEGF) by an
enzyme-linked immunosorbent assay kit (R&D systems,
Minneapolis, MN). DCs were incubated with 20% cancer
supernatant or medium as a control. After 6 d of incubation,
the DCs were examined for surface expression of CD11b,
j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 6 ( 2 0 1 4 ) 1 9 2e2 0 0194programmed death ligand 2 (PD-L2), CD86, and major
histocompatibility complex (MHC)-II within CD11cþ pop-
ulations, using FACSDiva software (Becton Dickinson, San
Diego, CA).
Following 24 h of incubation with supernatant, the DCs
were incubated for 10 min with 5 mg/mL of FITC-conjugated
dextran (DX) (70,000 Da molecular weight; Sigma, St. Louis,
MO) at 4C or 37C, washed extensively, and then examined
for FITC signals by CD11cþ cells.Fig. 1 e CD11b immunohistochemistry and CD11b and CD11c d
embedded sections of primary gastric cancer. Immunohistoche
The sections are counterstained with hematoxylin (blue). CD11b
CD11bD cells have a dendrite and are morphologically considere
at 3100 (A) and 3200 (B). A high number of stromal CD11bD ce
fluorescence immunohistochemistry (E), CD11b immunofluores
immunofluorescence staining (red fluorescence) (G). The coloca
pictures.2.6. Statistical analysis
Statistical analysis was performed using SPSS 13.0 statistical
software (SPSS Inc, Chicago, IL). We examined the association
between tumor-infiltrating CD11b-, CD8-, and FOXP3-positive
cells and other clinicopathologic variables, and the signifi-
cance of different prognostic markers using binomial logistic
regression analysis. The association with overall survival was
analyzed initially by a Kaplan-Meier plot and the log-rank test,ouble fluorescence immunohistochemistry in paraffin-
mistry of CD11bD cells (brown) in gastric carcinoma tissue.
D cells were predominantly present within the tumor area.
d to be DCs or macrophages. A low number of CD11bD cells
lls at 3100 (C) and 3400 (D). CD11b and CD11c double
cence staining (green fluorescence) (F), and CD11c
lization of CD11bD and CD11cD cells is shown in merged
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coefficients were used to determine the relationship between
the dependent variable and the possible explanatory vari-
ables, establishing the order of entrance in the multivariate
analysis. To adjust for other prognostic indicators, the Score
statistics and Likelihood ratio test were used to test for
significance in multivariate models. Backward and stepwise
model procedures were used to identify covariate most
strongly associated with overall survival. A P value of <0.05
was considered significant.3. Results
3.1. Correlation between the number of tumor-
infiltrating CD11bþ APCs and clinicopathologic features
CD11bþ cells were found predominantly in tumor stroma
with dendritic morphology (Fig. 1AeD). In double fluores-
cence immunohistochemistry, almost all CD11bþ cells
showed CD11c, which is a marker for the presence of DCs
and macrophages (Fig. 1EeG). The median number of
CD11bþ cells in the primary tumor and surrounding areasTable 1 e Correlation of CD11b expression with
clinicopathologic characteristics in gastric cancer.
Variables N CD11bþ cells P
value
HR (95% CI)
Low
(n ¼ 159)
High
(n ¼ 55)
Gender
Male 157 118 39 0.633 1.181 (0.597e2.335)
Female 57 41 16
Age 159 55 0.945 0.999 (0.973e1.026)
Histologic type
Intestinal 132 104 28 0.058 0.548 (0.295e1.021)
Diffuse 82 55 27
Tumor size 214 159 55 0.025 1.009 (1.001e1.017)
T
1 21 17 4 0.120 1.292 (0.935e1.786)
2 32 27 5
3 34 25 9
4 127 90 37
N
0 44 36 8 0.011 1.465 (1.093e1.964)
1 53 44 9
2 55 40 15
3 62 39 23
V
() 139 112 27 0.005 2.471 (1.318e4.635)
(þ) 75 47 28
Ly
() 38 31 7 0.261 1.661 (0.686e4.022)
(þ) 176 128 48
Stage
1 16 13 3 <0.001 2.558 (1.574e4.255)
2 71 60 11
3 111 83 28
4 16 3 16
CI ¼ confidence interval; HR ¼ hazard ratio.was 60. We next divided the entire cohort into two groups
according to the median number of CD11bþ cells. A
comparison of the clinicopathologic features of the study
patients between the high and low CD11bþ groups is
shown in Table 1. The intratumoral infiltration of CD11bþ
cells was significantly associated with very large tumor
size, positive venous invasion (V), lymph node metastasis
(pN), and tumor, node, metastasis stage (pStage). There
was a tendency but not significant association with diffuse
type.
The patients in the high CD11b group had poor survival
compared with the low CD11b group (Fig. 2). The median
survival of the high CD11b patients was 25.4 mo compared
with 43.0 mo in the low CD11b group (P < 0.0013). With regard
to prognostic factors, univariate analysis showed that the
number of intratumoral CD11bþ cells was significantly
correlated with poor prognosis, the same as with respect to
other general clinical factors, tumor size, positive venous
invasion (V), positive lymphatic invasion (Ly), extent of the
primary tumor (pT), pN, and pStage. In multivariate analysis,
high CD11b infiltration was one of the independent prog-
nostic factors, as well as pN and very large tumor size
(Table 2).3.2. Effect of gastric cancer cells on phenotype of
monocyte-derived DCs
We examined the production of immunosuppressive cyto-
kines by the gastric cancer cell lines and the effect on the
expression of costimulatory molecules by DCs in vitro.100
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Fig. 2 e High CD11bD cell count in cancer tissue indicates
poorer outcome in gastric cancer patients. Kaplan-Meier
survival curves of gastric carcinoma patients according to
the number of tumor-infiltrating CD11bD APCs are shown.
P values were calculated using the log-rank test between
the high CD11bD group and the low CD11bD group.
Patients in the high CD11bD group showed a significantly
poorer prognosis than patients in the low CD11bD group.
Table 2 e Univariate and multivariate analysis of overall survival by Cox model in gastric cancer.
Variables Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Gender 1.048 (0.625e1.579) 0.858 e e
Age 1.006 (0.985e1.028) 0.575 1.003 (0.981e1.025) 0.799
Histologic type 1.131 (0.694e1.840) 0.622 e e
INF 1.809 (0.251e13.030) 0.556 e e
Tumor size 1.009 (1.005e1.014) <0.001 1.009 (1.003e1.014) <0.001
V 1.810 (1.127e2.909) 0.014 1.120 (0.653e1.922) 0.680
Ly 2.114 (1.012e4.417) 0.046 0.792 (0.301e2.086) 0.637
T 1.615 (1.202e2.171) 0.001 1.343 (0.958e1.882) 0.087
N 1.680 (1.328e2.126) 0.001 1.537 (1.179e2.003) 0.001
Stage 3.930 (2.493e6.194) <0.001 e e
High CD11bþ cell infiltration 1.003 (1.001e1.005) 0.005 1.905 (1.134e3.200) 0.015
CI ¼ confidence interval; HR ¼ hazard ratio; INF ¼ pattern of infiltrating growth.
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TGF-b, IL-10, and VEGF, were detected by enzyme-linked
immunosorbent assay. The gastric cell lines OCUUM-2M,
OCUM-8, and OCUM-2MD3, which were derived from patients
with scirrhous gastric cancer, produced more immunosup-
pressive cytokines than the other cell lines (Fig. 3). Then, we
used the supernatants of the OCUM cell lines for subsequ-
ent experiments. The surface molecule expression of the
monocyte-derived DCs was examined within the CD11cþ pop-
ulations. The addition of the supernatants of the OCUM cells
reducedMHC-II expression and induced CD11b and PD-L2 onto
the surface of the DCs (Fig. 4AeC). Treatment with the cancer
supernatants increased the endocytic capacity of the CD11cþ
DCs (Fig. 4D).OCUM-8
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Fig. 3 e Secretion of immunosuppressive cytokines by gastric c
VEGF (C) in the culture supernatants derived from eight gastric
immunosorbent assay. IL-10 was detected in OCUM-8 and OCUM
or minimal levels. In almost all cell lines, TGF-b and VEGF were3.3. Correlation of CD11bþ cells with tumor-infiltrating
regulatory T cells
To evaluate the role of intratumoral CD11bþ cells, we
counted the number of regulatory T cells (Tregs) in the same
sections that were used in the analysis of CD11b infiltration.
Tumor-infiltrating Tregs and CD8þ cells were predominantly
localized in the stromal compartment, intratumoral stroma,
and invasive margin (Fig. 5). The median number of Tregs in
the intratumoral stroma and invasive margin was 90, we
divided the entire cohort into two groups according to the
median number of Tregs. Higher Treg density was correlated
with pN and pStage (Table 3). In addition, there was a strong
positive association between Tregs and tumor-infiltratingpg/ml
CUM-8
CUM-2M
CUM-12
CUM-2MD3
MKN45
MKN74
KATO
0 10 20 30
ancer cell lines. Concentration of TGF-b (A), IL-10 (B) and
cancer cell lines measured by enzyme-linked
-2M at medium levels and in the other supernatants at low
detected.
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Fig. 4 e Effect of gastric cancer cells on CD11cD APCs. The expression of CD11b, MHC-II, and PD-L2 on APCs cultured alone or
in the presence of gastric cancer cell supernatant was quantitatively assessed by flow cytometry. (A) CD11b expression,
(B) MHC-II expression, and (C) PD-L2 expression. (D) Endocytic activity of APCs was examined by FITC-dextran uptake.
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of CD8þ lymphocyte infiltration on survival (data not
shown).4. Discussion
In this study, we initially observed that intratumoral CD11bþ
cells were significantly associated with the progression ofFig. 5 e FOXP3 and CD8 immunohistochemistry in paraffin-em
expression of FOXP3D cells in intratumoral stroma. (B) Low exp
expression of FOXP3D cells in invasive margin. (D) Low express
of CD8D cells in intratumoral stroma. (F) Low expression of CD8
cells in invasive margin. (H) Low expression of CD8D cells in ingastric cancer. Next, we demonstrated the inhibitory effect of
gastric cancer cell lines on the phenotype of DCs in vitro and
a strong correlation between CD11bþ cells and tumor-
infiltrating Tregs. We found that high CD11bþ cells infiltra-
tion was an independent prognostic factor of gastric cancer
patients, as well as lymph node metastasis and tumor size.
Our findings suggest that the antitumor immune response
was inhibited through phenotypic changes of APCs in the
tumor microenvironment.bedded sections of primary gastric cancer. (A) High
ression of FOXP3D cells in intratumoral stroma. (C) High
ion of FOXP3D cells in invasive margin. (E) High expression
D cells in intratumoral stroma. (G) High expression of CD8D
vasive margin. (magnification, 3200).
Table 3 e Correlation of FOXP3 expression to
clinicopathologic characteristics in patients with gastric
cancer.
Variables N FOXP3 P value HR (95% CI)
Low
(n ¼ 108)
High
(n ¼ 106)
Gender
Male 157 81 76 0.585 1.184 (0.645e2.173)
Female 57 27 30
Age 108 106 0.345 1.011 (0.988e1.035)
Histologic type
Intestinal 127 66 61 0.342 0.765 (0.440e1.329)
Diffuse 87 42 45
Tumor size 108 106 0.525 1.002 (0.995e1.010)
T
1 21 10 11 0.818 1.031 (0.796e1.335)
2 32 12 20
3 34 23 11
4 127 63 64
N
0 44 29 15 0.019 1.345 (1.050e1.724)
1 53 28 25
2 55 24 31
3 62 27 35
V
() 139 70 69 0.441 0.757 (0.372e1.539)
(þ) 75 38 37
Ly
() 38 23 15 0.174 1.642 (0.803e3.354)
(þ) 176 85 91
Stage
1 16 14 2 0.016 1.593 (1.090e2.328)
2 71 33 38
3 111 57 54
4 16 4 12
CI ¼ confidence interval; HR ¼ hazard ratio.
j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 6 ( 2 0 1 4 ) 1 9 2e2 0 0198Increased tumor-infiltrating CTL and Th1 cells are associ-
ated with favorable prognosis of patients with many types of
cancer such as colorectal cancer, breast cancer, gallbladder
cancer, and hepatocellular carcinoma [15e18]. This effect is
induced by the antitumor immune response. However, the
detailed mechanism of this remains unclear. APCs, such as
macrophages and DCs, can directly activate antigen-specific
Th1 or CTLs, which can activate the antitumor immune
response. There have been several reports that tumor-
infiltrating APCs are associated with tumor progression and
poor prognosis. For example, infiltration of CD163þ M2Table 4 e Association among the number of tumor-
infiltrating CD11bD, FOXP3D, and CD8D cells.
CD11b FOXP3 CD8
Average P value Average P value
CD11b high
(n ¼ 54)
149.8  81.8 0.002 271.4  121.8 0.127
CD11b low
(n ¼ 160)
92.8  67.9 313.7  148.5macrophages, which have poor antigen-presenting capacity
and low IL-12, high IL-10, and VEGF production, have been
found to be correlated with poor prognosis in large B-cell
lymphoma and breast cancer [2,19,20]. In addition, several
studies have investigated the maturation and localization of
DCs in the tumor environment. Tumor-infiltrating CD1aþ DCs
have been associated with unfavorable prognosis of patients
with colorectal cancer and lung cancer [5,7,8]. In contrast, high
expression of CD208 or CD86 DCs has been reported to
contribute toward good prognosis in colorectal cancer, gastric
cancer, and malignant melanoma [5,6,21]. Thus, tumor-
infiltrating APCs have dual characteristics, which include the
capacity of triggering an antitumor or protumor immune
response, and this is dependent on their polarization. In the
present study, we found a strong correlation between an
increased number of tumor-infiltrating CD11bþCD11cþ APCs
and poor prognosis of patients with gastric cancer, suggesting
that the tumor-infiltrating CD11bþ DCs had “immature”
status.
We showed that cancer supernatant, in which the
included amount of immunosuppressive cytokines, induced
CD11b and PD-L2 expression and reduced MHC-II on the
surface of monocyte-derived DCs in vitro. DCs treated with
cancer supernatant also increased endocytic capacity.
Previous reports showed that tumor conditioned medium
obtained from renal cell carcinoma and melanoma increased
endocytic function of monocyte-derived DC by tumor-
derived prostaglandin E2 [22e24]. Augmentation of endocy-
tosis by DCs might be associated with increased secretion of
endoplasmic reticulum chaperone in the supernatant of
cancer cells [25]. It has been reported that pancreatic cancer
cells or lung cancer cells produce TGF-b, IL-10, and VEGF and
that prostaglandin E2 inhibits maturation of DCs and induces
the proliferation of Tregs [26e28]. Our findings suggest that
gastric cancer cells, which produce immunosuppressive
cytokines such as TGF-b and IL-10, have the potential to skew
the phenotypes of DCs in the proximity of cancer into
immature DCs and induce anergy of CTLs or proliferation of
Tregs.
A previous report showed that CD11bþ DCs were potent
inducers of antigen-specific IL-10, producing type 1 regula-
tory T cells that induced antigen-specific tolerance [29]. We
showed a positive correlation between CD11bþ cells and Tregs
in tumors, indicating that tumor-infiltrating CD11bþCD11cþ
cells could have the potential to induce Tregs in the tumor
environment of gastric cancer.
We did not completely distinguish CD11bþ cells between
macrophages and DCs because CD11bþ DCs and tumor-
associated M2 macrophages have similar characteristics in
inducing immune tolerance [2e4]. However, our results
suggest that DCs, which have more professional APCs
compared with macrophages, could change their phenotypes
in the tumor and induce a locally antitumor immune
response.
In conclusion, our study showed that tumor-infiltrating
CD11bþ APCs affected local tumor cell-immune cell interac-
tions and correlated with poor prognosis in patients with
gastric cancer. Our findings have important implications for
the contribution of CD11bþAPCs in local immune suppression
in the tumor environment of gastric cancer.
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Fig. 6 e Correlation between CD11bD and FOXP3D cells infiltration. (A) The degree of infiltration of CD11bD and FOXP3D cells
was plotted. There was a significant correlation between CD11bD APCs and Tregs. (B) The degree of infiltration of CD11bD
and CD8D cells was plotted. There was no significant correlation between the two types of cells. Pearson correlation test was
used for statistical analysis.
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